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Abstract
Following the sequencing of the human genome, the mapping of the human proteome is
the next task to being completed in order to gain knowledge on how proteins are
involved in disease genesis, growth, therapy, and healing. As contrary to the genome,
which is relatively static, the human proteome is significantly more complex and highly
dynamic. Whilst the majority of the research is being focused on analyzing either the
proteome of tumor tissues and tumor cells or the proteome of serum and plasma, little
attention has been awarded to the analysis of proteomes in saliva or urine. The prote-
ome in saliva can help providing important information on processes involving health
issues in dentistry, head and neck cancers, gastric cancers or neurology, to name just a
few. However, this is changing and the proteomics research community is increasingly
focusing on deciphering the salivary proteome. So far, more than 3000 proteins have
been identified in different studies and more is to come with new instrumentation and
methods available. Some of the proteomics methods applied for analysis of salivary
proteins will be discussed in this chapter.
Keywords: salival, proteomics, diagnostics, biomarkers, chromatography, mass
spectrometry
1. Introduction
The raise of proteomics and the continuous development and improvement of analytical instru-
ments such as high-performance liquid chromatography (HPLC) and mass spectrometry (MS)
have substantially fuelled the development of instrumental methods for analysis of proteins for
both research and clinical questions [1–6]. Proteomics is not only addressing the efficient separa-
tion of peptides upon, mostly, tryptic digestion of proteins and their sensitive detection using
mass spectrometry. Proteomics is a technology enabling significantly and profoundly better
approach to investigating and understanding proteins’ function and their posttranslational mod-
ifications [7–12]. Applying proteomics methods for analysis of clinical samples is especially
important in time of personalized medicine, which tailors individualized treatment of each
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patient based on specification of the diseases [3, 13–19]. Furthermore, (clinical) proteomics can be
used as a method-of-choice for the screening of biomarkers used for early discovery and early
diagnostics. Early diagnostics and early discovery, needless to say, will help decreasing patients’
morbidity and mortality by detecting the disease at the stage when it can be effectively treated
with less side effects and at significantly lower cost for the society. This approach can be very
beneficial especially for diseases affecting large populations such as cardiovascular diseases,
diabetes mellitus and other endocrinal diseases, glioblastoma and similar.
Proteomics can also be applied for the point-of-care diagnostic approaches where both medi-
cal professionals and patients can get rapid information and bed-side diagnosis. Of course,
classic proteomics approaches with protein extraction from tissue or body fluids and over-
night protein digestion cannot be applied; however, proteomics can provide information to be
used with kits for point-of-care approach [20–24].
It has already been shown that saliva is a highly valid biological fluid that can be used for
diagnostic applications [25–39].
Various number of components can be identified in saliva, which provides real-time data on
the patient’s condition. The substances found in saliva include but are not limited to DNA,
RNA, proteins, metabolites, and microbiota from both oral and gastrointestinal origin. Sample
collection is simple, cheap, and can be provided by patient at home without expensive equip-
ment or medical personal needed on-site.
This manuscript will provide a short insight into different techniques applied for proteomics
analysis of saliva starting with sample collection, protein precipitation and digestion, peptide
separation and MS detection, and finally with data analysis.
2. Sample collection
For medical or biological analysis in general, the method how and when a sample is being
collected is of utmost importance. Sample collection is one of the pre-analytical steps that need
extraordinary caution and that can influence, badly in most cases, the complete process of
sample analysis.
Saliva is mainly composed of water; however, there are a number of other substances being
present. Mucins, proteins, DNA, RNA, enzymes, sugars, cell debris, and microbiota and their
secretome can interfere with test performance. Therefore, an optimized sample collection
process is needed, and a researcher must carefully and cautiously prepare the sample collec-
tion step, and the patient must be educated and trained if sample is being to be collected at
home. Furthermore, steps like sample storage and transport to the laboratory must also be
carefully planned and executed especially when longitudinal studies of the same patient or of
the patients’ groups are being performed, and especially in parts of the world where appro-
priate infrastructure is not always available [40–45].
Several methods can be applied for collection of saliva: (1) passive droll is the simplest
approach but the saliva often has a high concentration of mucins and high viscosity and (2)
the Salivette® Systems [46–48], the Greiner Bio-One Saliva Kit, and the recently introduced
Salivary Glands - New Approaches in Diagnostics and Treatment68
RNA-Prosal [49]. All three sample collection systems have been used in the field, and publica-
tions describing their efficacy are available [50–52].
At the Proteomics Core Facility of the Medical University of Vienna Salivette® is being used for
induced saliva sample collection by chewing cotton swabs. As mentioned previously, it is of
great importance to carefully plan and perform sample collection. The patient or the donor
must retain from consuming food, alcoholic beverage, and caffeine at least for 2 h before
sample collection. Further, the patient shall briefly wash the mouth using water only. Saliva is
being collected for 2 min during which the patient chews the cotton swab. This approach
yields approximately 2.5 ml of saliva, which is sufficient for performing proteomics analysis.
Some patients, however, need additional stimulation for saliva production and paraffin gum
can be used in these cases to stimulate saliva flow and gain enough sample volume. In these
cases, the use of Greiner Bio-One Kit helps obtaining more saliva than chewing the cotton
swab; however, one shall be careful since this kit contains citric acid, which can lead to protein
denaturation and protein loss during the sample collection.
As soon as the sample has been collected it shall be supplemented with enzyme inhibitors in
order to suppress enzyme activity and protein degradation. A total protease inhibitor cocktail
such as Roche’s “Complete Protease Inhibitor Cocktail®” is being added to the sample follow-
ing centrifugation and removal of cellular debris and prior to storage at 80C.
It is of extreme importance to secure reproducible sample collection procedures and properly
train the patients in cases of self-sampling to avoid sample contamination and alteration.
Furthermore, conditions for proper sample transportation and handling until it is being
processed must also be carefully considered and applied.
Table 1 shows the steps applied for sample collection and the preparative work.
Step Device Temperature Precautions
1. Sample collection Salivette® (used in the Proteomics
Core Facility at the Medical
University in Vienna)
Human body No food, alcoholic or caffeine
beverages until 2 h before sample
collection!
2. Centrifugation Centrifuge 4C





Sample should always be prepared
on ice!
4. Depletion of high abundant
proteins
Antihuman serum albumin and Anti-




Pay attention to columns’
loadability!
5. Enzymatic digest Offline digest overnight 37C
6. (Multidimensional) HPLC
separation and MS detection of
tryptic peptides
Nano HPLC and mass spectrometer Various
combinations
Column capacity, compatibility of
selected separation dimensions
7. Bioinformatics-Database search Various platforms are available Not relevant Carefully select parameters, avoid
very stringent but also very lax
conditions
8. Verification and Validation
Table 1. General description of sample preparation for proteomics analysis of salivary samples.
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3. Sample preparation: depletion of abundant proteins and
enzymatic digest
The enzymatic digest of salivary proteins does not differ from digestion of other proteins. Usually,
trypsin is being used for proteolytic cleavage of proteins due to its relatively high specificity,
availability, and ease of use. Furthermore, tryptic peptides are ideally suited for reversed phase
HPLC separation and positive ionization using electrospray MS (ESI). Tryptic peptides are also
ideal for using multidimensional separation approaches such as strong cation exchange (SCX),
hydrophilic interaction liquid chromatography (HILIC), or electrostatic repulsion interaction
chromatography (ERLIC) since they bear positive charges on N-terminus or Lys-residues.
Beside trypsin, other proteases can also be used alone or in combination with trypsin. The aim
is either to achieve specific cleavage of proteins for special questions or to achieve smaller
peptides and enhance their ionization, detection, and ultimately better sequence coverage for
identified proteins. Mostly, proteins such as Lys-C and GluC are applied for pre-digestion
before trypsin addition.
Protein digest begins with protein precipitation from saliva. A number of methods have been
developed for protein precipitation such as: (1) alcoholic; (2) salting out; (3) applying strong acids
(trichloroacetic acid); (4) using acetone; (5) using acetonitrile, etc. Protein precipitation shall help
for removing DNA and RNA and their fragments from the sample and for removing lipids.
The Proteomics Core Facility of the Medical University in Vienna applies a modified Wessel-
Fluegge [53] method for protein precipitation [54]. Figure 1 shows the sample collection steps
prior to protein reduction, alkylation, and addition of the protease.
In addition to trypsin, the use of proteases, e.g. LysC, will help generating smaller peptides
prior to separation and detection [55, 56].
Figure 1. Sample collection steps prior to protein reduction, alkylation, and addition of the protease as performed at the
Proteomics Core Facility of the Medical University of Vienna (https://www.sarstedt.com/en/products/diagnostic/salivasputum/
product/51.1534.500/).
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Unlike serum or plasma, saliva does not contain large range and amounts of high abundant
proteins such as serum albumin or hemoglobin that can affect sensitivity and selectivity of
detection. However, amylase and serum albumin are still proteins with the highest abundance
in saliva and can also affect the detection of other low abundant species and should be
removed from the sample [57, 58]. In human saliva, alpha-amylase makes about 60% of the
abundance of all proteins present, and its removal will help identifying proteins of lower
abundance such as cytokines, which can be used as putative biomarkers for different pro-
cesses. Deutsch et al. [57] have shown a simple yet very effective method for removing alpha-
amylase and gaining a deeper insight into saliva’s proteome. The use of a simple potato starch
resulted in sixfold reduction of the amount of alpha-amylase in the sample. Albumin removal
can be facilitated by using a number of columns developed and based on immunoaffinity
reactions [59].
Figure 2. Comparison of the number of identified proteins from human saliva by applying different proteases. Courtesy
of Zofia Świątczak (Master Thesis).
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Enzymatic digest of salivary proteins does not differ from enzymatic digests used for other
biological samples. Based on previous experience and results, trypsin is the most widely used
protease for protein digest resulting with peptides suited for subsequent separation using
cation exchange columns or anion exchange columns, reversed phase separation, and mass
spectrometric detection. A comparison of results obtained using different digestion methods
for salivary samples obtained from healthy donors is shown in Figure 2.
As shown, the highest number of proteins was identified upon applying a combined digestion
approach and using GluC and trypsin. However, the choice of proteases used also depends on
analytical problem to be addressed as, e.g. for detection of glycosylated proteins, which might
require additional proteases to be applied.
4. Chromatographic separation of digested proteins
Upon tryptic digestion of proteins, resulting peptides are being separated on a chromatographic
column prior tomass spectrometric detection and subsequent bioinformatics analysis. Separation
of peptides is being performed either using one-dimensional approach or the multidimensional
separation by combining two or more separation technologies prior toMS detection and analysis.
For the one-dimensional chromatographic separation approach, peptides are being injected onto
the reversed phase nano HPLC column where they are separated according to their hydrophobic
interaction with the stationary phase [60]. Figure 2 shows an exemplary base peak chromato-
gram (BPC) for one-dimensional analysis separation of salivary peptides. Usually, long separa-
tion gradients are selected for one-dimensional separation in order to provide the best possible
conditions for peptide separations and large number of identifications.
Figure 3. Base Peak Chromatogram (BPC) of GluC-tryptically generated peptides, which were separated on a reversed
phase nano HPLC column.
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The separation shown in Figure 3was performed using a 180-min gradient and a total analysis
runtime of 210 min. Thus, the total amount of available time must be considered when
performing this kind of analysis.
The use of multidimensional separation methods will increase the number of peptides detected
and the number of identified proteins, and, in addition, protein's sequence coverage will be
Figure 4. A number of combinations of different techniques can be used for separation of peptides and proteins in a
proteomics approach.
Figure 5. Two-dimensional separation approach for salivary peptides enables identification of higher number of proteins.
Data courtesy of Zofia Świątczak (Master Thesis).
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improved for identified proteins. Improved sequence coverage for identified proteins is one of
the major challenges for proteomics analysis with high importance since it enhances chances
for detection of posttranslational modifications (PTM) such as phosphorylation, glycosylation,
methylation, etc., which are important as drug targets.
Different types of separation approaches can be used for the two-dimensional approach:
strong cation exchange columns, weak anion exchange columns, reversed phase columns at
high pH, and other combinations are possible [61–63]. A schematic of possible combinations of
chromatographic approaches is shown in Figure 4.
Generally, the use of multidimensional separation will result in increased number of identifi-
cations, and Figure 5 shows the comparison of the number of detected proteins upon applying
the two-dimensional chromatographic separation with strong cation exchange column used
for the first separation dimension.
5. Mass spectrometric detection and bioinformatics analysis
Upon separation, peptides are being detected using mass spectrometry and analyzed by com-
paring experimental data and databases of in-silico digested proteins. Several MS approaches
have been applied for detection of salivary peptides: Electrospray Time-of-Flight (ESI-ToF),
MALDI-Time-of-Flight (MALDI-ToF), ESI-Orbitrap analysis, ESI-Quadrupole ToF, etc.
Depending on MS type and selected instrumental method, posttranslational modifications
of proteins can also be identified and thoroughly analyzed thus enabled a deeper insight into
the proteome. The majority of top-down analysis, i.e. analysis of undigested proteins is
performed using MALDI mass spectrometers, and the majority of analysis for digested
proteins (peptides) is performed using electrospray (ESI) ionization and ToF and Orbitrap
mass analyzer.
The analysis of obtained raw data is performed by searching protein databases such as
SwissProt, Uniprot, NR (by NCBI), and user-generated databases. A number of commercially
available software packages such as Mascot (Matrix Science, London), ProteinScape (Bruker,
Germany), Proteome Discoverer (Thermo Scientific, Bremen, Germany), and of free available
software such as The Global Proteome Machine (www.thegpm.org), MaxQuant (http://www.
coxdocs.org/doku.php?id=maxquant:start), PeptideShaker (http://www.uib.no/en/rg/probe/
65218/peptideshaker), Skyline (https://skyline.ms/project/home/begin.view?), OpenMS (https://
www.openms.de/), and other packages. The choice of the software to be used strongly depends
not only on personal preferences but also on data to be analyzed and the information needed to
be extracted.
Figure 6 shows a screenshot of two software packages preferably used at the Proteomics Core
Facility at the Medical University of Vienna, Peptide Shaker and ProteinScape.
In addition to database search and protein identification, the analysis of the pathways where
proteins are being over- or underexpressed and the analysis of interactions with other proteins
have been performed using free software such as DAVID® (https://david.ncifcrf.gov/), STRING
(https://string-db.org/), Reactome (http://reactome.org/) or commercially available MetaCore®
(http://lsresearch.thomsonreuters.com/) or similar.
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Figure 6. Screenshots showing analysis of a salivary sample by applying two distinct software packages. Note that
identified proteins have been listed based on their scores, which can be calculated using different algorithms.
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Figure 7. Pathway analysis of salivary proteins using DAVID® resulted in expected output and identification of salivary
secretion as the pathway with the highest number of expressed proteins. Data courtesy of Zofia Świątczak (Master Thesis).
Salivary Glands - New Approaches in Diagnostics and Treatment76
An exemplary result of the pathway analysis of a salivary sample using DAVID® is shown in
Figure 7.
Finally, the analysis of all generated data and extracted information shall enable detection of
putative biomarkers for diseases and therapy monitoring.
6. Application of salivary proteomics analysis for clinical research
As already mentioned, analysis of the salivary proteome can be applied to study a large area of
conditions and diseases. The most intensively studied area of saliva as a diagnostic tool was its
appliance for dental [21, 57, 64, 65], oral cancer [31, 66], diabetes [67, 68] or gastric cancer [58].
Furthermore, salivary proteomics was also applied for studying neurological and psychiatric
disorders [69].
6.1. Application of salivary proteomics for diagnostics of oral diseases
The use of proteomics for diagnostics and treatment of oral diseases has been described in a
number of publications. Jancsik et al. [70] describe the use of salivary proteomics to identify
squamous oral cancer in diabetes patients. Authors have performed an additional sample
homogenization, which is rarely described in other approaches to analyze saliva. Following
analysis was performed by applying 2D gel separation of proteins and MS analysis using
MALDI-TOF without the previous chromatographic separation and fractionation of proteins.
It is known that inflammatory processes have a well-documented carcinogenetic role. Patients
suffering from type-2 diabetes have also a higher risk of inflammatory diseases in the gastro-
intestinal tract such as ulcerative colitis or Crohn’s disease. These patients have also a higher
risk of developing gastrointestinal cancer. It was shown that the incidence of developing
benign tumors, leukoplakia, and malignancies was significantly increased in the group of
patients with diabetes than in the healthy control group. The authors have shown a discovery
of several putative biomarkers such as, e.g. Annexin A8-like, Annexin A8-like 1, Tyrosine
kinase, AX969656, Protein kinase, Peroxiredoxin-2, and Annexin A2. Annexins are known to
be overexpressed in colorectal cancer but also to have altered in tumorigenesis in several types
of tumor. Furthermore, loss of Annexin A1 has been found to be an early event in esophageal
squamous cell carcinoma. Obviously, these results show that diabetic patients have a higher
risk of developing esophageal squamous cell carcinoma than the control healthy group and
close monitoring shall be applied for early detection.
Delaleu et al. [71] have performed a particularly interesting and thorough investigation of the
salivary proteome from patients suffering from Sjörgen’s syndrome. Salivary proteome was
analyzed using a 187-plex capture antibody-based assay, and the salivary proteomic bio-
marker profiles were generated from patients with primary Sjörgen’s syndrome, patients with
rheumatoid arthritis, and from asymptomatic controls. Authors were able to characterize
putative biomarkers by detecting significant changes in 61 and 55 proteins, respectively, in
samples of patients compared to that of donors without the diagnosis of Sjörgen’s syndrome.
Authors were able to detect, based on 4-plex and 6-plex biomarker signatures, markers
Proteomics of the Salivary Fluid
http://dx.doi.org/10.5772/intechopen.72309
77
including interleukin-4 (IL-4), IL-5, and clusterin. Accurate prediction of an individual’s group
membership was achieved for at least 94% of cases.
Winck et al. [72] analyzed the salivary proteome in order to decipher the immune response in
oral cancer based on the salivary proteome and the extracellular vesicles isolated from saliva.
The authors were able to identify significant differences in processes related to inflammatory
and humoral immune responses, to peptidase inhibitor activity, iron coordination, and prote-
ase binding. Based on identifications achieved, the two classes of individuals (healthy versus
patients with Oral Squamous Cell Carcinoma) were distinguished with 90% accuracy based
solely on the proteomics data. The authors have used the label-free approach to quantify the
identified proteins. Although both groups of peptides share the great majority of identified
proteins, some identified proteins were present only in the healthy or only in the group
diagnosed with cancer. Authors described that out of many differentially expressed proteins,
only the protein peptidyl-prolyl cis-trans isomerase A (also known as cyclophilin-A) was
statistically significant in the analysis of the mean survival time of patients, with reduced
abundance of PPIA being a factor that may predict poor prognosis of OSCC patients.
6.2. Application of salivary proteomics for diagnostics of diabetes
Sedentary lifestyle paired with unhealthy food, environmental derogation, and stress situa-
tions have led to significant increase in diabetes patients worldwide. Early detection of bio-
markers would enable more efficient therapy and possible delay of the diseases onset or even a
prevention of the outbreak. Caseiro et al. [67] have described the use of proteomics to study
Diabetes mellitus (DM) type-1. Authors have performed a quantitative proteomics analysis
using the chemical proteomics approach and chemical labeling using iTRAQ. Here, sample
from patients diagnosed with diabetes and from healthy subjects was pooled and processed
prior to LC-MS/MS measurement and bioinformatics analysis of generated data. In addition to
performing iTRAQ labeling and quantitation, authors have chosen for separating peptides by
applying two-dimensional separation using high pH reversed phase chromatography. It is
remarkable that authors also identified endogenous salivary peptides that are mostly ignored
using MALDI-TOF and combined the results to identify more than 400 proteins. Authors used
the data obtained to evaluate protein expression for patients with retinopathy, nephropathy,
and no complications with the salivary proteome of healthy donors. Identification of the
bactericidal/permeability increasing protein-like 1 (BPI) and pancreatic adenocarcinoma
upregulated factor (PAUF) in the saliva of all diabetics clearly suggests that the activation of
the immune system in type 1 DM is the most prominent process. One of the proteins, BPI, is an
essential component of the innate immune system with bacteriostatic and bactericidal effects
against gram-negative bacteria through lipopolysaccharides binding. The PAUF is an endoge-
nous ligand of Toll-like receptor 2 (TLR2) and Toll-like receptor 4 (TLR4), and it is also
involved in the inflammatory response, which seems to be more pronounced and more prom-
inent in patients with retinopathy and nephropathy considering the high salivary levels of
alpha-2-macroglobulin, defensin alpha 3 neutrophil-specific, leukocyte elastase inhibitor, matrix
metalloproteinase-9, and neutrophil elastase.
As authors also performed analysis of the peptidome, interesting data were obtained that
supported the hypothesis that Diabetes Mellitus (DM)-related proteins have higher susceptibility
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to proteolysis and evidenced an increased content of some specific protein fragments in saliva,
which have been shown to be related with bacterial attachment and the accumulation of
phosphopeptides. Especially, the accumulation of phosphopeptides seems to be involved in
tooth protection against erosion and the level of their expression and phosphorylation might be
a measure for dental damage that can be sustained in diabetes patients. The proteolytic frag-
ments from bPRP1, bPRP2, and aPRP, in particular, might be considered for monitoring the
disease pathogenesis with potential use for as early detection markers.
Rao et al. [73] applied multidimensional HPLC-MS/MS proteomics analysis for investigation
of salivary proteins in patients with Diabetes Mellitus type-2. A Strong Cation Exchange
separation of tryptic peptides from saliva of diabetic, prediabetic, and healthy subjects was
performed prior to reversed phase separation and MS/MS detection. More than 400 proteins
were identified and characterized and label-free quantitation was applied. As with other
analysis, proteins involved with metabolic and inflammatory processes were detected in the
saliva of subjects with diabetes. An important finding of the study was achieved in the
prediabetic saliva: Salivary biomarkers of established Diabetes Mellitus were identified by
proteomic profiling to be also differentially abundant in the saliva of patients with impaired
glucose tolerance (IGT) alone and IGT + IFG (impaired fructose tolerance). These results were
further confirmed by direct Western immunoblot and ELISA analyses.
The authors showed that the relative increase of some of these putative markers is associated
with progression of prediabetes to the diabetic state. Therefore, systematic analysis of these
putative biomarkers in prediabetic saliva, as well as their variability in individual samples, by
immunoassays is of extreme importance for early acting and treatment of patients, which can
prevent cardiovascular complications and mortality in diabetes patients.
An important aspect of patients suffering from DM type-2 is the severe retinopathy that can
lead to blindness. Chee et al. [74] performed quantitative proteomics analysis of salivary pro-
teins from patients diagnosed with DM type-2 without retinopathy, which served as controls
and patients with DM type-2 and retinopathy. Quantitative proteomics analysis was per-
formed by applying iTRAQ labeling and peptide separation before MS/MS detection was
performed on a 50-cm nano column. Authors identified more than 300 proteins but have
selected only the fully labeled pairs for quantitative analysis, a total of 119 proteins. Authors
identified that increased proteins were predicted to be defense proteins and metabolic proteins
suggesting that the expression of salivary defense and metabolic proteins is related to diabetic
retinopathy. These results confirmed the report by Fernandez-Real et al. [75] that defense
response proteins were elevated in type-2 diabetic patients and this gradually led to surging
of metabolic proteins.
6.3. Application of salivary proteomics for psychiatric and neurological diseases
Fields of neurology and psychiatry urgently need new biomarkers for objective and earlier
diagnoses of conditions attributed to the central nervous system (CNS). Proteomics and other
“omics” technologies are being increasingly applied for these discoveries. Henskens et al. [76]
performed analysis of salivary proteins already in 1996 for patients treated with different
medications for epilepsy. This work was not performed by using nowadays technology, how-
ever, several salivary proteins in saliva from epileptic patients, who were medicated with
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different antiepileptic drugs (namely phenytoin, valproate, and carbamazepine), were found
to be increased and were compared with protein levels in the saliva of healthy control subjects.
It was also found that, for all patient groups, the specific amylase activity was increased up to
twofold. On the other side, absolute and relative concentrations of cystatin S were diminished
in all samples, but particularly strong in patients using either valproate or phenytoin. These
data suggest that use of antiepileptic drugs over long periods may cause a decrease of salivary
proteins such as sIgA and cystatins, which are involved in the protection of the oral cavity
against microbial infections and, therefore, these patients suffer more complications related to
gingiva and oral cavity in general.
Ngounou Wetie et al. [77] have investigated the use of salivary proteins as possible markers for
early onset of Autism Spectrum Disorders (ASDs). Authors have identified increased levels of
apolipoproteins apoA1 and apoA4 and of serum paraoxonase/arylesterase 1 (PON1) in ASD
sera compared to healthy controls in blood serum and have tested the hypothesis that levels of
these peptides might also be elevated in saliva. Authors found statistically significant differ-
ences in expression of a number of salivary proteins such as elevated prolactin-inducible
protein, lactotransferrin, Ig kappa chain C region, Ig gamma-1 chain C region, Ig lambda-2
chain C regions, neutrophil elastase, polymeric immunoglobulin receptor and deleted in
malignant brain tumors 1. Identifications made support the hypothesis that immune system
disturbances may be present in individuals with ASDs.
Castagnola et al. [78, 79] have applied a proteomics approach for studying the naturally
occurring peptidome of human saliva in children diagnosed with ASDs. The study revealed
that naturally occurring peptides in the saliva of children with ASD can bear multiple phos-
phorylations. The phosphorylation level of four specific salivary phosphopeptides, identified
in this study, statherin, histatin 1, and acidic proline-rich proteins for both entire and truncated
isoforms, was found to be significantly lower in autistic patients, with hypophosphorylation of
at least one peptide observed in 18 ASD subjects (66%). Authors suggest that different phos-
phorylation and hypophosphorylation of salivary peptides suggest potential asynchronies in
the phosphorylation of other secretory proteins. These proteins could be relevant in the devel-
opment of central nervous system during embryonic development or in early infancy. Further-
more, obtained results suggest that naturally occurring salivary phosphopeptides might help
to detect and discriminate a subgroup of ASD patients.
6.4. Application of salivary proteomics for dentistry
Saliva has a continuous and intensive contact and interaction with human teeth and plays an
important role in cleaning the tooth surface and antimicrobial defense. Salivary proteomics
and its role in dentistry have been studied in a number of experiments. Some of these have
addressed the role of salivary proteins in edentulous patients diagnosed with DM. Byrd et al.
and Border et al. [80, 81] have addressed the problem of edentulous patients with Denture
stomatitis (DS) and DM type-2.
Denture stomatitis refers to an inflammatory condition of the mucosal tissue underneath the
denture, which could lead to severe health problems. Clinical classification of DS distinguishes
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three types: type 1 (DS I), type 2 (DS II), and type 3 (DS III), referring to clinically localized
mild, localized moderate, and generalized tissue inflammation [80]. Authors have performed a
quantitative proteomics analysis based on label-free quantitation and using two different MS
platforms—an Orbitrap instrument and a Time-of-flight instrument. Interestingly, proteins
were detected as differentially expressed between the two LC/MS systems. Protein expression
was also different depending on the severity of DS. Authors have observed different levels of
protein expression between different stages of DS and between the number of identified and
quantified proteins for different disease stages and have identified serum proteins in the saliva
of patients with DS III, e.g. ceruloplasmin, hemoglobins, serotransferrin, and albumin, which
suggest that DS III patients experience higher level of inflammation and protein leakage from
blood into saliva.
An interesting approach has been undertaken by Kaczor-Urbanowicz et al. [82] to study tooth
absorption during an inflammatory process caused by orthodontic tooth movement. The
orthodontically induced inflammatory root resorption (OIIRR) occurs as a consequence (the
most prevalent and unavoidable) of orthodontic tooth movement. Authors have applied 2D-
gel separation for salivary proteins upon depletion of abundant proteins (amylase, serum
albumin, and IgG), and separated the tryptic peptides using HPLC followed by MS/MS
detection. Identified proteins were quantified using the label-free approach. Authors were able
to identify more than 700 proteins, which were revealed by quantitative MS of which different
numbers were identified for different groups of patients. The strength of this study lays with
the depth of the analyzed proteome and the significance of the results. Authors performed the
bioinformatic analysis for proteins, which were found to be more than threefold increased.
Different patient groups revealed different results although they all have been diagnosed with
the tooth resorption. The moderate-to-severe root resorption young group revealed 38 func-
tional clusters associated with acute and dynamic processes and in the moderate-to-severe root
resorption adult group, other 16 functional clusters were found and those were related to less
dynamic and slower processes. For the young group, these processes included the regulation
of acute inflammatory response, defense response, response to stress, response to wounding or
healing as opposed to apoptosis, glycoproteins expression, cell adhesion, signal peptides, etc.
in the adult group with moderate-to-severe processes. Finally, a number of new putative bio-
markers were identified, and these might be used to produce a clinical test that would serve
along with radiography to perform a fast and more reliable diagnosis.
7. Conclusion
In summary, salivary proteomics is an upcoming approach for both basic and clinical research
with a significant potential for use in fast diagnostic approaches. Not only the analysis of
salivary proteins but also the analysis of endogenous peptides in saliva and their posttransla-
tional modifications shall be addressed and targeted. Although a number of studies have been
published and more are to come, more research is required to validate the discovered putative
biomarkers so far.
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Current proteomics approach for the analysis of oral fluid is not yet suited for daily routine in
clinical diagnostics. However, it can help discovering biomarkers for which immunological
tests such as ELISA can be developed.
Furthermore, it is essential to develop and curate a comprehensive database for the salivary prote-
ome and establish standard conditions for sample collection and processing until the MS analysis.
The space was scarce in this chapter to address more of the clinical approach of salivary proteo-
mics, but the researcher is encouraged to stay focused and follow the further development.
Current development shows that, without any doubt, this process will continue and will yield
more biomarker candidates in the future.
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